Daniel Patty, DPM
Primary Podiatric Medicine · Orem, UTNPI 1437445509
Payments from drug & device makers
Across 105 payments — averaging $33.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Active Medical, LLC$1K
- Linvatec Corporation$578
- Smith+Nephew$545
- Stryker$293
- Vaporox, Inc.$200
- Zyla Life Sciences, Inc.$191
- plus $480 from 14 others
What the payments were for
- Travel & lodging$57817%
- Food & beverage$1,70849%
- Education$1,20034%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Active Medical, LLC | 1 | $1,200 |
| Linvatec Corporation | 3 | $578 |
| Smith+Nephew | 56 | $545 |
| Stryker | 4 | $293 |
| Vaporox, Inc. | 1 | $200 |
| Zyla Life Sciences, Inc. | 22 | $191 |
| Organogenesis Inc. | 1 | $140 |
| Tactile Systems Technology Inc | 3 | $70 |
| Abbott | 1 | $55 |
| Stimlabs LLC | 2 | $33 |
| Medtronic | 2 | $32 |
| Bard Peripheral Vascular, Inc. | 1 | $27 |
| Medline Industries LP | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Solventum Corporation | 1 | $18 |
| Treace Medical Concepts, Inc. | 1 | $16 |
| Urgo Medical North America, LLC | 1 | $14 |
| Amgen | 1 | $12 |
| Anika Therapeutics, Inc. | 1 | $11 |
| Arthrosurface Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LINVATEC BURS AND BLADES$288
- LINVATEC ARTHROSCOPY$261
- PuraPly$140
- VARIAX$132
How this compares
Too few primary podiatric medicine providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Linezolid | 17 | $2,345 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 32 | $609 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $292 |
| Ondansetron Hcl | 13 | $102 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Orem
- Stanton SmithMurray$1K
- Kathryn DeckerSalt Lake City$954
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.